Shanghai Kindly Medical Instruments Co., Ltd. Class H (HK:1501)
:1501
Want to see HK:1501 full AI Analyst Report?
Top Page
Shanghai Kindly Medical Instruments Co., Ltd. Class H
(1501)
Select Model
Select Model
Rating:69Neutral
Price Target:
HK$37.00
▲(26.28% Upside)
Action:Reiterated
Date:04/25/26
The score is driven primarily by solid underlying financial performance (growth and strong 2025 cash flow rebound) tempered by higher leverage and margin compression. Technicals add support with price above major moving averages and positive momentum, while valuation is only moderate given the ~20.8 P/E and no dividend yield data.
Positive Factors
Revenue Growth Momentum
Sustained top-line acceleration to 12.7% in 2025 signals durable demand for the company’s hospital-focused consumables and devices. For a consumables-heavy model, recurring procedural demand and expanding penetration improve revenue visibility, supporting steady reinvestment in R&D and distribution over the medium term.
Negative Factors
Rising Leverage
A near threefold increase in debt within a year materially reduces financial flexibility and raises interest-service sensitivity. Higher leverage amplifies earnings volatility impact, limits capacity for opportunistic investment or dividend policy, and increases refinancing and covenant risk if cash flow weakens.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth Momentum
Sustained top-line acceleration to 12.7% in 2025 signals durable demand for the company’s hospital-focused consumables and devices. For a consumables-heavy model, recurring procedural demand and expanding penetration improve revenue visibility, supporting steady reinvestment in R&D and distribution over the medium term.
Read all positive factors
Shanghai Kindly Medical Instruments Co., Ltd. Class H (1501) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$7.37B
Dividend YieldN/A
Average Volume (3M)29.01K
Price to Earnings (P/E)21.4
Beta (1Y)-0.01
Revenue Growth25.24%
EPS Growth7.29%
CountryHK
Employees1,735
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)1.21
Shares Outstanding139,413,390
10 Day Avg. Volume19,260
30 Day Avg. Volume29,013
Financial Highlights & Ratios
PEG Ratio1.47
Price to Book (P/B)2.35
Price to Sales (P/S)4.40
P/FCF Ratio16.87
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.39
Revenue Forecast (FY)HK$1.23B
Shanghai Kindly Medical Instruments Co., Ltd. Class H Business Overview & Revenue Model
Company Description
Shanghai Kindly Medical Instruments Co., Ltd. engages in the research and development, manufacture, and sale of cardiovascular interventional medical devices in Mainland China, Europe, the United States, and internationally. The company offers int...
How the Company Makes Money
The company makes money primarily by selling its medical devices and disposable medical consumables to healthcare providers and distributors, generating revenue from product sales. Its revenue model typically includes: (1) domestic and potentially...
Shanghai Kindly Medical Instruments Co., Ltd. Class H Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
67
Positive
Cash Flow
61
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.07B | 851.95M | 752.84M | 585.88M | 464.68M |
| Gross Profit | 636.79M | 537.66M | 438.07M | 332.49M | 275.75M |
| EBITDA | 353.06M | 255.43M | 225.88M | 159.99M | 168.81M |
| Net Income | 218.79M | 191.91M | 156.46M | 131.71M | 142.96M |
Balance Sheet | |||||
| Total Assets | 3.13B | 2.26B | 2.03B | 1.83B | 1.62B |
| Cash, Cash Equivalents and Short-Term Investments | 651.85M | 554.51M | 434.40M | 528.27M | 640.55M |
| Total Debt | 716.26M | 243.69M | 94.78M | 48.83M | 13.40M |
| Total Liabilities | 1.04B | 473.39M | 351.25M | 273.23M | 183.63M |
| Stockholders Equity | 2.00B | 1.77B | 1.65B | 1.51B | 1.40B |
Cash Flow | |||||
| Free Cash Flow | 278.17M | 59.80M | -53.05M | -62.75M | -205.07M |
| Operating Cash Flow | 340.98M | 225.54M | 178.15M | 180.46M | 72.76M |
| Investing Cash Flow | -491.99M | -187.31M | -283.81M | -316.18M | -268.08M |
| Financing Cash Flow | 263.40M | 56.97M | 8.06M | 9.72M | -31.07M |
Shanghai Kindly Medical Instruments Co., Ltd. Class H Technical Analysis
Neutral
29.30
Price Trends
35.52
Negative
33.16
Positive
32.02
Positive
Market Momentum
-0.48
Positive
36.48
Neutral
15.85
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1501, the sentiment is Neutral. The current price of 29.3 is below the 20-day moving average (MA) of 37.67, below the 50-day MA of 35.52, and below the 200-day MA of 32.02, indicating a neutral trend. The MACD of -0.48 indicates Positive momentum. The RSI at 36.48 is Neutral, neither overbought nor oversold. The STOCH value of 15.85 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:1501.
Shanghai Kindly Medical Instruments Co., Ltd. Class H Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$5.32B | 8.37 | 16.76% | 3.65% | 11.07% | 48.01% | |
77 Outperform | HK$3.34B | 9.15 | 10.21% | 2.70% | 9.88% | 5.65% | |
69 Neutral | HK$7.37B | 21.45 | 11.20% | ― | 25.24% | 7.29% | |
67 Neutral | HK$1.74B | 18.55 | 3.68% | 7.46% | 7.11% | -34.66% | |
66 Neutral | HK$12.57B | ― | 5.12% | ― | ― | ― | |
62 Neutral | HK$15.92B | 12.88 | 6.64% | 4.58% | 2.34% | -22.25% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
HK:1501
Shanghai Kindly Medical Instruments Co., Ltd. Class H
34.04
8.59
33.75%
HK:1066
Shandong Weigao Group Medical Polymer Co
3.48
-2.00
-36.46%
HK:1358
PW Medtech Group Ltd.
1.18
0.21
21.90%
HK:3600
Modern Dental Group Limited
5.77
1.91
49.37%
HK:6699
Angelalign Technology Inc.
72.20
19.53
37.07%
HK:6929
OrbusNeich Medical Group Holdings Limited
4.38
0.85
24.08%
Shanghai Kindly Medical Instruments Co., Ltd. Class H Corporate Events
Shanghai INT Medical Wins Approval for Major H-Share Conversion
May 13, 2026
Shanghai INT Medical Instruments Co., Ltd. has received approval from the Hong Kong Stock Exchange to list 71,786,608 converted H shares, which will be created through the conversion of an equivalent number of domestic shares held by 12 existing s...
Shanghai INT Medical to Acquire 23.18% Stake in Target Company for US$108 Million
May 12, 2026
Shanghai INT Medical Instruments Co., Ltd. has agreed to acquire a 23.18% equity stake in an unnamed target company for US$107.76 million, comprising a mix of ordinary and preferred shares. The acquisition price is equivalent to about RMB737.79 mi...
Shanghai INT Medical Instruments Wins CSRC Nod for H-Share Full Circulation Plan
May 11, 2026
Shanghai INT Medical Instruments has obtained a filing notice from the China Securities Regulatory Commission approving its application to convert 71,786,608 domestically held shares into H shares. The move, involving 12 existing shareholders, aim...
Shanghai INT Medical to Take Full Control of Pulin Medical via RMB31 Million Stake Purchase
Apr 29, 2026
Shanghai INT Medical Instruments Co., Ltd. has moved to consolidate its control over Pulin Medical, a key operating subsidiary, by acquiring the remaining 35% minority equity stake for a total consideration of RMB31.29 million. The transaction wil...
Shanghai INT Medical Moves to Acquire Valgen Medtech Stake to Bolster Heart Device Portfolio
Apr 28, 2026
Shanghai INT Medical Instruments Co., Ltd. plans to acquire up to 90% of Valgen Holding Corporation, parent of Hangzhou Valgen Medtech, for no more than RMB1.5 billion to deepen its presence in structural heart disease devices. Valgen Medtech spec...
Shanghai INT Medical Sets 2026 AGM to Approve Results, Budget and Share Buyback Mandate
Apr 22, 2026
Shanghai INT Medical Instruments Co., Ltd. has called its annual general meeting for 28 May 2026 in Shanghai, where shareholders will review reports from the board and supervisory committee, the 2025 annual report, audited group financial statemen...
Shanghai Kindly Medical Declares Final 2025 Dividend for H Shareholders
Mar 27, 2026
Shanghai Kindly Medical Instruments Co., Ltd. has declared a final ordinary cash dividend of RMB 0.23 per share for the financial year ended 31 December 2025, equivalent to HKD 0.26 per H share based on an exchange rate of RMB 1 to HKD 1.135. The ...
Shanghai Kindly Medical Posts Double-Digit Profit Growth on Rising Interventional Device Sales
Mar 27, 2026
Shanghai Kindly Medical Instruments Co., Ltd. reported strong growth for the year ended 31 December 2025, with revenue rising 25.06% year on year to RMB1.07 billion, driven by an expanded customer base and business combinations. Sales of intervent...
Shanghai INT Medical Instruments Sets Board Meeting to Approve 2025 Results and Consider Dividend
Mar 17, 2026
Shanghai INT Medical Instruments Co., Ltd., a Hong Kong-listed Chinese medical device manufacturer, announced that its board includes a mix of executive, non-executive and independent non-executive directors led by Chairman Dr. Liang Dongke. The c...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.